Cetera Investment Advisers boosted its stake in Genpact Limited (NYSE:G - Free Report) by 288.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,526 shares of the business services provider's stock after buying an additional 38,257 shares during the quarter. Cetera Investment Advisers' holdings in Genpact were worth $2,596,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Coppell Advisory Solutions LLC increased its holdings in Genpact by 529.5% during the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the period. Cornerstone Planning Group LLC purchased a new position in Genpact during the 1st quarter worth approximately $27,000. Richardson Financial Services Inc. acquired a new position in Genpact during the first quarter worth approximately $35,000. GeoWealth Management LLC increased its position in Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after buying an additional 583 shares during the period. Finally, Global X Japan Co. Ltd. purchased a new stake in Genpact in the first quarter valued at approximately $57,000. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Stock Performance
Shares of NYSE:G traded up $1.87 during midday trading on Friday, hitting $43.59. The stock had a trading volume of 2,940,103 shares, compared to its average volume of 1,610,910. Genpact Limited has a 1 year low of $35.42 and a 1 year high of $56.76. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. The stock has a 50 day moving average price of $43.84 and a two-hundred day moving average price of $47.12. The company has a market capitalization of $7.62 billion, a PE ratio of 14.88, a P/E/G ratio of 1.60 and a beta of 0.92.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. The company had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The firm's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.79 EPS. As a group, equities analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.6%. Genpact's dividend payout ratio is 23.21%.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genpact in a research report on Thursday, July 17th. They set a "hold" rating and a $47.00 target price on the stock. Robert W. Baird lowered their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Needham & Company LLC reaffirmed a "buy" rating and issued a $53.00 target price (up from $50.00) on shares of Genpact in a report on Friday. Wall Street Zen raised Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Finally, Mizuho upped their price objective on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Five analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Genpact presently has a consensus rating of "Moderate Buy" and an average target price of $50.13.
Read Our Latest Research Report on G
Insider Buying and Selling at Genpact
In related news, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was bought at an average cost of $43.97 per share, with a total value of $87,940.00. Following the completion of the acquisition, the director owned 2,000 shares in the company, valued at approximately $87,940. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.07% of the stock is currently owned by company insiders.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.